FIELD: medicine.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry, namely to suppositories for treating moderate and high-intensity pain syndrome. Rectal suppository pharmaceutical composition contains 0.1–10 g/100 g of nefopam or its pharmaceutically acceptable salt, from 10 % to 100 % of particles of which have size from 90 mcm to 1000 mcm, and up to 100 g/100 g of a lipophilic base with pharmaceutically acceptable additives selected from a preserving agent, an emulsifying agent and a stabilizer or mixtures thereof.
EFFECT: invention provides prolongation of analgesic effect and shelf life of composition more than 2 years.
7 cl, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723958C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723954C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723960C1 |
PHARMACEUTICAL COMPOSITIONS AS RECTAL SUPPOSITORIES CONTAINING NEFOPAM HYDROCHLORIDE (VERSIONS), THEIR APPLICATION FOR TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME AND METHODS FOR PRODUCTION | 2015 |
|
RU2646495C2 |
NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A HYDROPHILIC EMULSION BASED AND METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661617C1 |
NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A LIPOPHILIC BASIS AND THE METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661618C1 |
PHARMACEUTICAL COMPOSITION CONTAINING NALBUPHINE HYDROCHLORIDE, USING IT FOR TREATING MODERATE TO SEVERE PAIN SYNDROME | 2012 |
|
RU2513514C1 |
PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
AGENT OF PEPTIDE STRUCTURE POSSESSING ANTI-INFLAMMATORY, ANTIBACTERIAL, WOUND-HEALING, REGENERATIVE, ANALGESIC, BURNTREATING ACTION AND BASED DOSAGE FORMS | 2012 |
|
RU2517213C2 |
METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
Authors
Dates
2020-06-18—Published
2019-11-12—Filed